Skip to content
Search

Latest Stories

CPPE creates Covid-19 learning resource hub for pharmacists

The Centre for Pharmacy Postgraduate Education (CPPE) has created a Covid-19 learning hub to support pharmacy professionals through the pandemic.

The resource hub aims to enable community pharmacists to find all the resources that they may need to update themselves.


Community pharmacists can access a collection of resources for a variety of topics such as returning to pharmacy practice, looking for the latest Covid-19 resources, seeking support or resilience, among others.

It also includes a guide to 'returning to pharmacy practice', which aims to support pharmacy professionals making a comeback to community or hospital pharmacy after a gap.

The guide has a self-assessment framework to help the professionals to identify the key areas pharmacists need to visit to refresh their knowledge for practice.

Pharmacy professionals will also have access to daily Zoom drop-in sessions to provide them with additional support.

The advanced learning section in the hub contains more specific clinical guidance and information on medicines including various e-learning resources.

The section on seeking support and resilience links new resilience page where the user can find information on how to build resilience and deal with stressful situations.

More For You

Community Pharmacy Scotland secures £10m reimbursement uplift amid ongoing negotiations

Negotiations continue on the Global Sum element of remuneration.

Getty Images

Community Pharmacy Scotland secures £120m reimbursement deal for 2025/26

Community Pharmacy Scotland (CPS) has accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

The agreement marks the first phase of ongoing negotiations surrounding community pharmacy funding for the upcoming financial year.

Keep ReadingShow less
NICE approves once-daily tablet Linzagolix for endometriosis

NICE recommends Linzagolix with add-back therapy for endometriosis

Image credit: Getty Images

NICE approves new at-home treatment for endometriosis

The National Institute for Health and Care Excellence (NICE) has recommended Linzagolix (brand name Yselty), a once-daily tablet, as a new treatment option for endometriosis.

Developed by Theramex, Linzagolix is approved for use alongside hormonal add-back therapy in adults of reproductive age who have previously tried other medical or surgical treatments for the condition.

Keep ReadingShow less
Many patients report inaccuracies or missing details in their NHS medical records

Inaccurate information can result in serious harm or even death, warns Healthwatch England.

Image Credit: Getty Images

1 in 4 adults have spotted errors in their NHS medical records, survey finds

Healthwatch England has raised the alarm over the risks posed by inaccurate medical records as research reveals widespread errors in NHS patient information.

Commissioned by Healthwatch England and conducted by BMG Research, the survey polled a representative sample of 1,800 adults in England between 24 and 27 March 2025.

Keep ReadingShow less
RPS and HEIW extend independent prescribing learning programme for pharmacists in Wales

The programme is designed to support pharmacists delivering the Pharmacy Independent Prescribing Service in Wales.

gettyimages

Independent prescribing learning programme for pharmacists in Wales extended till 2028

The Royal Pharmaceutical Society (RPS) and Health Education and Improvement Wales (HEIW) have announced a three-year extension of their successful learning programme designed to support pharmacists delivering the Pharmacy Independent Prescribing Service (PIPS) in Wales.

Originally launched in 2024, the programme equips pharmacists with the essential knowledge, skills, and confidence needed to provide excellent patient care as independent prescribers.

Keep ReadingShow less